Toward the development of criteria for global flares in juvenile systemic lupus erythematosus

Arthritis Care and Research

Volumn 62, Issue 6, 2010, Pages 811-820

  Brunner, Hermine I ^a   Klein Gitelman, Marisa S ^b   Higgins, Gloria C ^c   Lapidus, Sivia K ^d   Levy, Deborah M ^e   Eberhard, Anne ^f   Singer, Nora ^g   Olson, Judy Ann C ^h   Onel, Karen ⁱ   Punaro, Marilynn ^j   Schanberg, Laura ^k   Von Scheven, Emily ^l   Ying, Jun ^a   Giannini, Edward H ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h CHILDREN S HOSPITAL OF WISCONSIN   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CREATININE; DOUBLE STRANDED DNA ANTIBODY; PROTEIN;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOBAL FLARE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN-ENDED QUESTIONNAIRE; ORGAN; PATIENT CODING; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; WELLBEING;

ADOLESCENT; CHILD; DATA COLLECTION; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHYSICIANS; PROSPECTIVE STUDIES;

EID: 77953103899     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20126     Document Type: Article

References (28)

1. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008;58:556-562
2. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008;152:550-556
3. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006;85: 147-156 (Pubitemid 43833013)
4. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566-570 (Pubitemid 39128326)
5. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, et al, for the Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum 2006;55:355-363
6. Buyon JP, Petri M, Kim M, Kalunian K, Grossman J, Hahn B, et al, for the SELENA Investigators. Estrogen/cyclic progesterone replacement is associated with an increased rate of mild/ moderate but not severe flares in the SLE Patients in the SELENA Trial [abstract]. Arthritis Rheum 2003;48:3659-3660
7. Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, et al, for the Systemic Lupus International Collaborating Clinics. Systemic Lupus International Collaborating Clinics renal activity/ response exercise: comparison of agreement in rating renal response. Arthritis Rheum 2008;58:1789-1795
8. Ruperto N, Ravelli N, Murray KJ, Lovell DJ, Anderrson-Gare B, Feldman BM, et al. Preliminary core set of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-1459 (Pubitemid 37508918)
9. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
10. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-1118
11. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29: 288-291
12. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-458 (Pubitemid 23223653)
13. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999;42:1354-1360
14. Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis 1996;55: 756-760 (Pubitemid 26354438)
15. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al, and the European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992;10:549-554
16. Masood S, Jayne D, Karim Y. Beyond immunosuppression: challenges in the clinical management of lupus nephritis. Lupus 2009;18:106-115
17. Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009;18: 257-263
18. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:527-535 (Pubitemid 43200347)
19. Tafeit E, Moller R, Sudi K, Reibnegger G. ROC and CART analysis of subcutaneous adipose tissue topography (SATTop) in type-2 diabetic women and healthy females. Am J Human Biol 2000;12:388-394
20. Breiman L. Classification and regression trees. Boca Raton (FL): Chapman & Hall/CRC; 1998.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
22. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428
23. Brunner HI, Higgins GC, Wiers K, Lapidus SK, Olson JC, Onel K, et al. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus. J Rheumatol 2009;36:1536-1545
24. Caldwell JR, Furst DE, Smith AL, Clark JA, Bonebrake RA, Gruhn WB, et al. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study. J Rheumatol 1998;25:30-35
25. Balsa A, Carmona L, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol 2004;31:40-46 (Pubitemid 38067520)
26. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-352
27. Hinze C, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer N, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009;60:2772-2781
28. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008;29:150-164 (Pubitemid 351952461)